Muyong, Esnia C.
HRN: 24-44-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2024
CEFUROXIME 1.5GM (VIAL)
01/17/2024
01/24/2024
IVT
1.5 Gm
Q 8h
S/P CS W/ BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes